NCT05098210
- Conditions
- Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
- Locations
-
- Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
Clinical trial condition
Pathologic Stage IIID Cutaneous Melanoma AJCC v8
Explore clinical trials studying Pathologic Stage IIID Cutaneous Melanoma AJCC v8. Study availability and eligibility vary by location and protocol.
13 public trials
3 recruiting studies
Pathologic Stage IIID Cutaneous Melanoma AJCC v8 trial results
NCT03819296
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +61 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
Recruiting
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
NCT05039801
- Conditions
- Adnexal Diseases, Advanced Endometrial Carcinoma, Advanced Head and Neck Squamous Cell Carcinoma, +71 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States
NCT03554083
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage III Cutaneous Melanoma AJCC v8, Pathologic Stage IIIA Cutaneous Melanoma AJCC v8, +3 more
- Locations
-
- Mayo Clinic in Florida Jacksonville, Florida, United States
- University of Minnesota/Masonic Cancer Center Minneapolis, Minnesota, United States
- Mayo Clinic in Rochester Rochester, Minnesota, United States
Active, Not Recruiting
Social Health, Activity Behaviors, and Quality of Life Among Young Adult Cancer Survivors
NCT07259304
- Conditions
- Adenocarcinoma, Adnexal Diseases, Anatomic Stage I Breast Cancer AJCC v8, +158 more
- Locations
-
- Los Angeles General Medical Center Los Angeles, California, United States
- USC / Norris Comprehensive Cancer Center Los Angeles, California, United States
- MD Anderson Cancer Center Houston, Texas, United States
Active, Not Recruiting
Using Biomarkers to Help Guide Safe Immunotherapy Discontinuation in Patients With Unresectable Stage IIIB-IV Melanoma, The PET-Stop Trial
NCT04462406
- Conditions
- Advanced Melanoma, Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, +8 more
- Locations
-
- Thomas Hospital Fairhope, Alabama, United States
- Mobile Infirmary Medical Center Mobile, Alabama, United States
- Fairbanks Memorial Hospital Fairbanks, Alaska, United States
- Cancer Center at Saint Joseph's Phoenix, Arizona, United States
Active, Not Recruiting
Gene-Modified T Cells With or Without Decitabine in Treating Patients With Advanced Malignancies Expressing NY-ESO-1
NCT02650986
- Conditions
- Adnexal Diseases, Advanced Fallopian Tube Carcinoma, Advanced Malignant Solid Neoplasm, +78 more
- Locations
-
- Roswell Park Cancer Institute Buffalo, New York, United States
Active, Not Recruiting
Tacrolimus, Nivolumab, and Ipilimumab in Treating Kidney Transplant Recipients With Selected Unresectable or Metastatic Cancers
NCT03816332
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Basal Cell, +42 more
- Locations
-
- Moffitt Cancer Center - McKinley Campus Tampa, Florida, United States
- Moffitt Cancer Center Tampa, Florida, United States
- Northwestern University Chicago, Illinois, United States
- Johns Hopkins University/Sidney Kimmel Cancer Center Baltimore, Maryland, United States
Active, Not Recruiting
A Study Evaluating Whether Pembrolizumab Alone or in Combination With CMP-001 Improves Efficacy of Treatment in Patients With Operable Melanoma
NCT04708418
- Conditions
- Clinical Stage III Cutaneous Melanoma AJCC v8, Melanoma, Melanoma of Unknown Primary, +15 more
- Locations
-
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
- Alaska Oncology and Hematology LLC Anchorage, Alaska, United States
- Alaska Women's Cancer Care Anchorage, Alaska, United States
Active, Not Recruiting
VX15/2503 With or Without Ipilimumab and/or Nivolumab in Patients With Resectable Stage IIIB-D Melanoma
NCT03769155
- Conditions
- Pathologic Stage IIIB Cutaneous Melanoma AJCC v8, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Pathologic Stage IIID Cutaneous Melanoma AJCC v8
- Locations
-
- Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States